Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Dutasteride and finasteride affect different cell types differently.

Removing anthrax toxin receptor 1 in pigs prevents Senecavirus A infection and causes a rare disease similar to GAPO syndrome.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Removing vitamin D and calcium receptors in mice skin cells slows down skin wound healing.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

TNF-alpha inhibitors can cause various immune-related skin issues.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.